The majority of human cutaneous melanomas are driven in part by constitutive activation of the MAPK pathway through mutation of genes such as BRAF, NRAS, NF1, KIT, GNAQ, and GNA11, often in a mutually exclusive pattern [99]. This evidence concerns the gene BRAF and cutaneous melanoma.